Public Justice Joins U.S. Supreme Court Battle against Pharmaceutical Companies' Bid for Complete Immunity from Failure-to-Warn Laws
August 14, 2008
August 14, 2008
WASHINGTON, Aug. 14 -- Trial Lawyers for Public Justice issued the following news release:
Arguing that FDA approval should not exempt drug manufacturers from liability for inadequate drug labels, Public Justice has joined a high-profile case before the U.S. Supreme Court that will decide whether federal law preempts failure-to-warn claims for prescription drugs.
Public Justice's amicus brief in Wyeth v. Levine was filed August 14th on behalf of 10 current and . . .
Arguing that FDA approval should not exempt drug manufacturers from liability for inadequate drug labels, Public Justice has joined a high-profile case before the U.S. Supreme Court that will decide whether federal law preempts failure-to-warn claims for prescription drugs.
Public Justice's amicus brief in Wyeth v. Levine was filed August 14th on behalf of 10 current and . . .